GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

Smith & Nephew SNATS SNN · USD

Health Care · US listing · 🇺🇸 United States

Compare

31.05

-0.32%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2025

Revenue

$6.16bn

FY2016FY2025

Net income

$625.0m

FY2016FY2025

Free cash flow

$852.0m

FY2016FY2025

Shareholders' equity

$5.29bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue$6.16bn$5.81bn$5.55bn$5.21bn$5.21bn$4.56bn$5.14bn$4.90bn$4.76bn$4.67bn
Gross profit$4.21bn$4.08bn$3.90bn$3.70bn$3.70bn$3.18bn$3.81bn$3.61bn$3.52bn$3.40bn
Research and development$346.0m$343.0m$339.0m$345.0m$356.0m$307.0m$292.0m$246.0m$223.0m$230.0m
Operating income$794.0m$657.0m$425.0m$450.0m$593.0m$295.0m$815.0m$863.0m$934.0m$801.0m
Net income$625.0m$412.0m$263.0m$223.0m$524.0m$448.0m$600.0m$663.0m$767.0m$784.0m
Diluted earnings per share1.430.940.300.260.600.510.680.760.880.88

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets$10.46bn$10.35bn$9.99bn$9.97bn$10.92bn$11.01bn$9.30bn$8.06bn$7.87bn$7.34bn
Cash and short-term investments$557.0m$619.0m$302.0m$350.0m$1.29bn$1.76bn$277.0m$365.0m$169.0m$100.0m
Total liabilities$5.17bn$5.09bn$4.77bn$4.71bn$5.35bn$5.73bn$4.16bn$3.19bn$3.22bn$3.39bn
Debt$3.33bn$3.32bn$3.08bn$2.87bn$3.34bn$3.69bn$2.05bn$1.47bn$1.45bn$1.65bn
Shareholders' equity$5.29bn$5.26bn$5.22bn$5.26bn$5.57bn$5.28bn$5.14bn$4.87bn$4.64bn$3.96bn
Shares outstanding436m440m873m870m878m880m876m874m874m890m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations$1.28bn$987.0m$608.0m$468.0m$877.0m$935.0m$1.17bn$931.0m$1.09bn$849.0m
Capital spending−$433.0m−$381.0m−$427.0m−$358.0m−$408.0m−$443.0m−$408.0m−$347.0m−$376.0m−$320.0m
Free cash flow$852.0m$606.0m$181.0m$110.0m$469.0m$492.0m$760.0m$584.0m$714.0m$529.0m
Dividends paid−$330.0m−$327.0m−$327.0m−$327.0m−$329.0m−$328.0m−$318.0m−$321.0m−$269.0m−$279.0m

Latest quarters

By quarter end

Jun 2026Dec 2025Jun 2025Dec 2024Jun 2024Mar 2024Dec 2023Sept 2023
Revenue$3.10bn$3.20bn$2.96bn$2.98bn$2.83bn$1.41bn$2.81bn$1.41bn
Gross profit$2.20bn$2.12bn$2.09bn$2.10bn$1.97bn$987.0m$2.00bn$997.0m
Operating income$448.0m$365.0m$429.0m$329.0m$328.0m$164.0m$150.0m$203.5m
Net income$303.0m$332.0m$293.0m$198.0m$214.0m$107.0m$91.0m$45.5m
Diluted earnings per share0.700.760.670.450.490.240.100.05
Cash from operations$450.0m$889.0m$396.0m$749.0m$238.0m$119.0m$495.0m$247.0m
Capital spending−$190.0m−$294.0m−$139.0m−$209.0m−$172.0m−$86.0m−$260.0m−$130.0m
Free cash flow$260.0m$595.0m$257.0m$540.0m$66.0m$33.0m$235.0m$117.0m
Total assets$11.01bn$10.46bn$10.68bn$10.35bn$10.54bn$10.54bn$9.99bn$9.99bn
Cash and short-term investments$754.0m$557.0m$675.4m$619.0m$568.0m$568.0m$302.0m$302.0m
Debt$573.0m$3.33bn$3.45bn$3.32bn$3.65bn$380.0m$3.08bn$765.0m
Shareholders' equity$5.18bn$5.29bn$5.53bn$5.26bn$5.21bn$5.21bn$5.22bn$5.22bn

Financial ratios

Data as of 2 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin68.3%70.2%70.2%70.9%71.0%69.7%
Operating margin12.9%11.3%7.7%8.6%11.4%6.5%
Net margin10.1%7.1%4.7%4.3%10.1%9.8%
Return on equity11.8%7.8%5.0%4.2%9.4%8.5%
Return on assets6.0%4.0%2.6%2.2%4.8%4.1%
Free cash flow yield14.8%11.7%4.5%3.6%5.5%5.9%
Revenue growth6.1%4.7%6.4%0.1%14.3%-11.2%
Earnings growth51.7%56.7%17.9%-57.4%17.0%-25.3%
Current ratio2.57x2.89x1.77x2.25x2.08x2.76x
Debt to equity0.60x0.61x0.56x0.52x0.57x0.67x
Equity ratio50.6%50.8%52.2%52.8%51.0%47.9%
Interest coverage5.62x4.38x3.21x5.63x7.41x4.72x
R&D as a share of sales5.6%5.9%6.1%6.6%6.8%6.7%
Buybacks as a share of market value0.8%49.6%-0.4%0.9%0.3%-0.5%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue5.7%6.2%2.9%
Operating income20.8%21.9%2.4%
Net income41.0%6.9%4.3%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin69.2%69.8%70.0%71.7%
Operating margin12.1%10.2%9.9%12.8%
Net margin8.7%6.7%7.7%10.1%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings22.926.290.5104.958.082.970.249.339.934.1
Price to sales2.31.94.34.55.88.18.26.76.45.7

Market value over time

30 Nov 2016 to 1 Oct 2026, in USD

$25.34bn$11.44bn

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return31%-7%2%-18%-23%-13%30%6%17%-15%

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.